Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

HCW Biologics (HCWB) Invested Capital (2020 - 2025)

Historic Invested Capital for HCW Biologics (HCWB) over the last 6 years, with Q3 2025 value amounting to -$2.1 million.

  • HCW Biologics' Invested Capital rose 3991.21% to -$2.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$2.1 million, marking a year-over-year increase of 3991.21%. This contributed to the annual value of $607693.0 for FY2024, which is 9692.56% down from last year.
  • As of Q3 2025, HCW Biologics' Invested Capital stood at -$2.1 million, which was up 3991.21% from $315179.0 recorded in Q2 2025.
  • HCW Biologics' Invested Capital's 5-year high stood at $54.0 million during Q3 2021, with a 5-year trough of -$23.2 million in Q2 2021.
  • Its 5-year average for Invested Capital is $22.7 million, with a median of $25.0 million in 2023.
  • Per our database at Business Quant, HCW Biologics' Invested Capital soared by 40620.9% in 2021 and then tumbled by 11161.22% in 2024.
  • Quarter analysis of 5 years shows HCW Biologics' Invested Capital stood at $51.2 million in 2021, then dropped by 14.37% to $43.8 million in 2022, then tumbled by 54.91% to $19.8 million in 2023, then tumbled by 96.93% to $607693.0 in 2024, then crashed by 446.75% to -$2.1 million in 2025.
  • Its Invested Capital was -$2.1 million in Q3 2025, compared to $315179.0 in Q2 2025 and -$856684.0 in Q1 2025.